SQSTM1 and amyotrophic lateral sclerosis: We then asked if the differential accumulation of p62-containing protein aggregates, a typical cytopathological feature of ALS patients and mouse models, could be explained by a differential use of the proteasome degradation pathway similar to what we observed by western blot.